Atherothrombotic ischemic stroke is associated with multiple vascular risk factors, including mainly hypertension, diabetes, and hyperlipidemia. Medical therapy of cerebral atherothrombosis implies control of these vascular risk factors and antithrombotic drugs as well. This paper reviews the current therapeutic guidelines according to the randomized trials for primary and secondary stroke prevention.
Laloux, P. (2004). Traitement médical de l’athérothrombose cérébrale. Journal de Pharmacie de Belgique, 59(1), 35-37. https://hdl.handle.net/2078.5/99537 (Original work published 2004)